SeaSpine Inc.

79 articles with SeaSpine Inc.

• SeaSpine to Participate in Upcoming Investor Conferences - Nov 08, 2021

  11/8/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will participate in upcoming virtual investor conferences.

• SeaSpine Announces Limited Commercial Launch of Mariner MIS Wayfinder

  11/1/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the limited commercial launch and completion of initial surgeries of the Mariner® MIS Wayfinder System.

• SeaSpine Reports Third Quarter 2021 Financial ResultsProvides Financial Outlook for Fourth Quarter 2021

  10/28/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended September 30, 2021.

• SeaSpine to Participate in the Cantor Virtual Global Healthcare Conference

  9/22/2021

  SeaSpine Holdings Corporation today announced the Company will present at the Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021, beginning at 8:00 am ET.

• SeaSpine to Host Analyst & Investor Event on September 30, 2021

  9/16/2021

  SeaSpine Holdings Corporation announced today that it will host an Analyst & Investor Event in Boston, Massachusetts on Thursday, September 30 from 7:30 a.m. to 8:45 a.m. Eastern Time.

• OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusively Distribute the 7D Surgical FLASH Navigation Platform for Pediatric Applications

  9/9/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced they have entered into a distribution agreement with SeaSpine® Orthopedics Corporation, a wholly-owned subsidiary of SeaSpine Holdings Corporation, to exclusively distribute the 7D Surgical FLASH™ Navigation platform for pediatric applications.

• SeaSpine Announces Limited Commercial Launch of the WaveForm® A (ALIF) 3D-Printed Interbody System

  8/12/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the limited commercial launch of its 3D-printed WaveForm A Interbody System.

• SeaSpine Reports Granting of Inducement Awards - Aug 05, 2021

  8/5/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to nine non-executive employees.

• SeaSpine Reports Second Quarter 2021 Financial Results

  8/2/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended June 30, 2021.

• SeaSpine to Participate in the Canaccord Genuity 41st Annual Growth Conference

  7/28/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will present at the Canaccord Genuity 41st Annual Growth Conference on Wednesday, August 11, 2021, beginning at 2:00 PM ET.

• SeaSpine to Report Second Quarter 2021 Financial Results on August 2, 2021

  7/26/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it will release second quarter financial results after the close of trading on Monday, August 2, 2021.

• SeaSpine Reports Granting of Inducement Awards - June 04, 2021

  6/4/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to Beau Standish and 44 non-executive employees in connection with the closing of its acquisition of 7D Surgical.

• SeaSpine Announces Closing of 7D Surgical Acquisition

  5/20/2021

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the previously announced acquisition of 7D Surgical.

• SeaSpine to Participate in the Canaccord Genuity Virtual Musculoskeletal Conference

  5/10/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will present at the Canaccord Genuity Virtual Musculoskeletal Conference on Thursday, May 20, 2021, beginning at 1:00 PM ET.

• SeaSpine Reports First Quarter 2021 Financial ResultsReaffirms 2021 Financial Outlook

  5/3/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended March 31, 2021.

• SeaSpine Prices Public Offering of Common Stock - Apr 16, 2021

  4/16/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock at a public offering price of $19.50 per share.

• SeaSpine Commences Public Offering of Common Stock - Apr 15, 2021

  4/15/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has commenced an underwritten public offering of shares of its common stock.

• SeaSpine Announces Preliminary Results for First Quarter 2021 and Increases 2021 Revenue GuidanceProvides Additional Financial Guidance for Pending Acquisition of 7D Surgical

  4/5/2021

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the first quarter of 2021 and provided updated revenue guidance for the full-year 2021. The Company also provided additional information regarding the expected financial impact of 7D Surgical in 2021 and 2022.

• SeaSpine Reports Granting of Inducement Awards - Feb 05, 2021

  2/5/2021

  SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to nine non-executive employees.

• SeaSpine Announces Limited Commercial Launch of Regatta® Lateral Plate System

  1/20/2021

  SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its Regatta Lateral Plate System.  Marking the first standalone lateral plate for SeaSpine, this Lateral Lumbar Interbody Fusion (LLIF) fixation system allows for multiple plating options, including one, two, and four-hole plates. The addition of